Wolverine Trading’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$827K Buy
+162,100
New +$716K ﹤0.01% 3108
2025
Q2
Sell
-17,400
Closed -$48.7K 4805
2025
Q1
$48.7K Buy
+17,400
New +$62.4K ﹤0.01% 4431
2024
Q2
Sell
-14,200
Closed -$40.5K 4500
2024
Q1
$40.5K Buy
14,200
+4,200
+42% +$13K ﹤0.01% 4251
2023
Q4
$35.3K Buy
+10,000
New +$28.7K ﹤0.01% 4325
2023
Q3
Sell
-13,200
Closed -$52.4K 4513
2023
Q2
$52.4K Buy
13,200
+2,600
+25% +$8.25K ﹤0.01% 3939
2023
Q1
$35K Buy
+10,600
New +$43.2K ﹤0.01% 3907
2022
Q3
Sell
-13,200
Closed -$58K 4607
2022
Q2
$58K Sell
13,200
-2,700
-17% -$19.5K ﹤0.01% 4028
2022
Q1
$136K Buy
+15,900
New +$112K ﹤0.01% 4666
2021
Q4
Sell
-26,100
Closed -$269K 5894
2021
Q3
$269K Buy
+26,100
New +$228K ﹤0.01% 4870
2021
Q2
Sell
-11,900
Closed -$126K 6010
2021
Q1
$126K Buy
+11,900
New +$166K ﹤0.01% 5330

Other funds holding SRTA

Wolverine Trading's SRTA Position: Q1 2025 in Review

Wolverine Trading sold out of Strata Critical Medical Inc (SRTA) in Q1 2025, closing a stake of 54,045 shares — an estimated $194K sold.

Wolverine Trading first reported a position in SRTA in Q2 2023 and held it in 4 quarters. The position peaked at $237K in Q4 2024. 118 funds tracked by Wall St. Rank hold SRTA as of Q1 2025.

  • Wolverine Trading reported no remaining Strata Critical Medical Inc position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 54,045 Strata Critical Medical Inc shares in Q1 2025, an estimated $194K.
  • Wolverine Trading first reported a position in Strata Critical Medical Inc in Q2 2023 and held it in 4 quarters.
  • Wolverine Trading's Strata Critical Medical Inc position peaked at $237K in Q4 2024.
  • 118 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.